Investors

Egetis is an innovative, unique, and integrated pharmaceutical drug development company, focusing on projects in late-stage development for treatment of serious rare/niche diseases with significant unmet medical needs in the orphan drug segment

Calendar

February 26, 2026 (7:00am CET) - Year-end Report Q4 2025
March 8-11, 2026 - Leerink Global Healthcare Conference (Miami, FL)
March 11-12, 2026 - DNB Carnegie Healthcare Conference (Stockholm)
April 15-16, 2026 - van Lanschot Kempen Life Sciences Conference (Amsterdam)
April 29, 2026 (7:00am CEST) - Interim Report Q1 2026
May 6, 2026 - Annual General Meeting

Share

Contact us

Address: Klara Norra Kyrkogata 26, SE 111 22 Stockholm, Sweden

Phone: +46 8 679 72 10

E-mail: [email protected]